Hereditary Clear Cell Renal Cell Carcinoma

Hereditary Clear Cell Renal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

3 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 100%
Top sponsor: Neomorph, Inc
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00727532	Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer	terminated	N/A	9	Northwestern UniversityOTHER	1	May 3, 2019	clinicaltrials

Data updated 22 days agoSource updated May 3, 2019source: clinicaltrials